Journal
MOLECULAR CELL
Volume 77, Issue 3, Pages 542-+Publisher
CELL PRESS
DOI: 10.1016/j.molcel.2019.11.007
Keywords
-
Categories
Funding
- Burroughs Wellcome Fund
- National Institutes of Health [R01AI125416, R21AI129851, 5P30AI064518, R01MH117406, R03HL135475]
- American Heart Association [17PRE33670017]
- National Science and Engineering Research Council of Canada
- Bert L. and N. Kuggie Vallee Foundation
- WorldQuant Foundation
- Pershing Square Sohn Cancer Research Alliance
- NASA [NNX14AH50G]
- UNC Lineberger Comprehensive Cancer Center
- NASA [NNX14AH50G, 683584] Funding Source: Federal RePORTER
Ask authors/readers for more resources
The RNA modification N-6-methyladenosine (m(6)A) modulates mRNA fate and thus affects many biological processes. We analyzed m(6)A across the transcriptome following infection by dengue virus (DENV), Zika virus (ZIKV), West Nile virus (WNV), and hepatitis C virus (HCV). We found that infection by these viruses in the Flaviviridae family alters m(6)A modification of specific cellular transcripts, including RIOK3 and CIRBP. During viral infection, the addition of m(6)A to RIOK3 promotes its translation, while loss of m(6)A in CIRBP promotes alternative splicing. Importantly, viral activation of innate immune sensing or the endoplasmic reticulum (ER) stress response contributes to the changes in m(6)A in RIOK3 or CIRBP, respectively. Further, several transcripts with infection-altered m(6)A profiles, including RIOK3 and CIRBP, encode proteins that influence DENV, ZIKV, and HCV infection. Overall, this work reveals that cellular signaling pathways activated during viral infection lead to alterations in m(6)A modification of host mRNAs to regulate infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available